The nine justices will then decide whether to leave access to the drug intact or require the U.S. Food and Drug Administration to revert prescribing instructions to what were in place before 2016.
We’re a reader-funded news organization fighting an expensive lawsuit that threatens our survival. Our reporting remains fiercely independent, and is never manipulated by commercial or political ties. And it’s free, for everyone. But if you can support us, we need you.
The nine justices will then decide whether to leave access to the drug intact or require the U.S. Food and Drug Administration to revert prescribing instructions to what were in place before 2016.